Safeguarding Our Future January 11, 2016 • admin • Helping to prevent neurological damage from pesticide poisoning. Related News Countervail competes and is selected for participation in the SBIR sponsored Commercialization Acceleration Program (CAP). October 14, 2015 Countervail holds initial pre-IND meeting with Neurology Division of the FDA for guidance on development of a neuroprotectant against sub-lethal nerve agent exposure. October 5, 2012
